Differential gene expression in the interactome of the Human Dopamine transporter in the context of Parkinson's disease
NAVARRO, R. C.; Ligia Scott, A.; Allison Philot, E.; Atencio, L.; Fernandez Ponce, C.; Aroca Martinez, G.; Cadena Bonfanti, A.; Gomez Escorcia, l.; Navarro Quiroz, E.
Show abstract
BackgroundThe human dopamine transporter is the main regulator of dopamine tone and an intricate network exists to regulate the expression, conformation, and kinetics of the hDAT. hDAT dysfunction is directly related to Parkinsons disease. The objective of this work is to evaluate the differential gene expression in the interactome of the Dopamine transporter in the context of Parkinsons disease. MethodsTo do this, we evaluated hDAT interaction data in string-db, mint.bio, IntAct, reactome, hprd and BioGRID, subsequently, data was obtained from the differential gene expression of mRNA and miRNAs for this hDAT interactome in the context of PD. ResultsThe analysis of the differential expression changes of genes of the hDAT interactome in tissues of patients with PD compared with tissues of individuals without PD, allowed to identify an expression pattern of 32 components of the hDAT interactome, of which 31 presented a negative change proportion in PD. ConclusionsWe found a total of 90 miRNAs that could regulate the expression of 27 components of the hDAT interactome, at the same time, 39 components of the hDAT interactome may participate in 40 metabolic pathways. Together, these findings show a systematic effect on the hDAT-mediated dopamine internalization process in patients with Parkinsons, which would contribute to a greater susceptibility to neuronal oxidative stress in PD patients.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- The Potential Regulation of A-to-I RNA editing on Genes in Parkinson's Disease 93%
- Structural variability, expression profile and pharmacogenetics properties of TMPRSS2 gene as a potential target for COVID-19 therapy 92%
- Reduced Expression of Slc Genes in the VTA and NAcc of Male Mice with Positive Fighting Experience 91%
Similar papers in this journal
- Different RNA profiles in plasma derived small and large extracellular vesicles of Neurodegenerative diseases patients. 96%
- Characterization of isolated human astrocytes from aging brain 95%
- DReAmocracy: A Method to Capitalize on Prior Drug Discovery Efforts to Highlight Candidate Drugs for Repurposing 94%
Similar papers in this journal
- A synthetic kinematic index of trunk displacement conveying the overall motor condition in Parkinson's disease 95%
- Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein 94%
- Developing and Validating a New Web-Based Tapping Test for Measuring Distal Bradykinesia in Parkinson's Disease 92%
Similar papers in this journal
- Beta2 -Adrenergic Agonists in Treatment for Parkinsonism, with Implications for Neurodegenerative and Neoplastic Disorders. 94%
- UBL3 Interacts with Alpha-synuclein in Cells and the Interaction is Downregulated by the EGFR Pathway Inhibitor Osimertinib 93%
- Ladostigil attenuates the oxidative and ER stress in human neuroblast-like SH-SY5Y cells 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.